Immune system, unleashed by cancer therapies, can attack organs – American Pharmacists Association

Immunotherapy drugs have been regarded as a breakthrough in cancer treatment, but as their use grows, doctors are finding that they pose serious risks.   A separate paper found that 30% of patients experienced “interesting, rare, or unexpected side effects,” with a quarter of the reactions described as severe, life-threatening, or requiring hospitalization. Some patients have died…Problems with the pancreas have been particularly unusual, causing patients typically aged 50 years and older to lose insulin production all at once.

Source: Immune system, unleashed by cancer therapies, can attack organs | American Pharmacists Association

Oops.

FDA Adds New Warnings to All Testosterone Product Labels

Testosterone and other AAS, which have a schedule III classification by the Controlled Substances Act, may be abused by adults and adolescents, including athletes and body builders.

“Abuse of testosterone, usually at doses higher than those typically prescribed and usually in conjunction with other AAS, is associated with serious safety risks affecting the heart, brain, liver, mental health, and endocrine system,” the FDA notes.

Reported serious adverse outcomes include myocardial infarction, heart failure, stroke, depression, hostility, aggression, liver toxicity, and male infertility. People abusing high doses of testosterone have also reported withdrawal symptoms, such as depression, fatigue, irritability, loss of appetite, decreased libido, and insomnia, the agency says.

Source: FDA Adds New Warnings to All Testosterone Product Labels

Source: Safety Alerts for Human Medical Products > Testosterone and Other Anabolic Androgenic Steroids (AAS): FDA Statement – Risks Associated With Abuse and Dependence

It is interesting you no longer see those Low-T commercials on television any more.  Really?  Just another clever marketing campaign to create a disease that doesn’t exist along with a convenient drug based solution.  What side effects?

Read this book.  Now.

Source: Bill Moyers Journal . Profile . Melody Petersen | PBS

Vital Signs: Disparities in Antihypertensive Medication Nonadherence Among Medicare Part D Beneficiaries — United States, 2014 – MMWR

Source: Vital Signs: Disparities in Antihypertensive Medication Nonadherence Among Medicare Part D Beneficiaries — United States, 2014 | MMWR

Conclusions and Implications for Public Health Practice:

More than one in four Medicare Part D beneficiaries using anti-hypertensives were non-adherent to their regimen, and certain racial/ethnic groups, states, and geographic areas were at increased risk for non-adherence.